BioCentury
ARTICLE | Clinical News

Lynovex cysteamine regulatory update

January 2, 2012 8:00 AM UTC

The European Commission granted Orphan Drug designation for NovaBiotics' Lynovex cysteamine to treat cystic fibrosis (CF). The dual mucoactive antibacterial is in preclinical testing for the indicatio...